+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood DNA Kit Market - Global Forecast to 2030- Product Image
Blood DNA Kit Market - Global Forecast to 2030- Product Image
New

Blood DNA Kit Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083387
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood DNA Kit Market grew from USD 936.38 million in 2024 to USD 997.18 million in 2025. It is expected to continue growing at a CAGR of 6.25%, reaching USD 1.34 billion by 2030.

The blood DNA kit market is undergoing a profound evolution, driven by breakthroughs in genomic technologies and shifting consumer expectations. By enabling individuals and professionals alike to access detailed genetic information, these kits have transcended mere novelty to become indispensable tools in healthcare, ancestry research, and wellness optimization. This report delivers an authoritative synthesis of the current landscape, highlighting pivotal trends, regulatory influences, and strategic considerations. Throughout the next sections, readers will gain a clear understanding of the forces reshaping product development, distribution channels, and competitive dynamics. As decision-makers seek to capitalize on emerging opportunities, this executive summary offers actionable insights and a rigorous analysis of segmentation, regional performance, and leading industry participants. By synthesizing technical innovation with practical market intelligence, the report equips stakeholders with the clarity needed to navigate complexity and position their organizations for sustained growth.

Transformative Shifts Shaping Industry Dynamics

In recent years, the landscape for blood DNA kits has been transformed by a convergence of technological, regulatory, and consumer-driven shifts. Next-generation sequencing has dramatically reduced turnaround times and broadened the spectrum of detectable genetic markers, empowering personalized medicine providers to deliver tailored treatment plans with unprecedented accuracy. At the same time, the expansion of direct-to-consumer channels has democratized access to genetic insights, encouraging widespread adoption beyond traditional healthcare settings. Regulatory bodies are responding by updating guidelines to ensure data privacy and assay reliability, fostering greater confidence among end users. Moreover, partnerships between diagnostic firms and digital health platforms are creating integrated ecosystems that seamlessly link genetic data with lifestyle interventions and clinical decision support tools. These transformative shifts underscore the growing importance of interoperability, data security, and consumer engagement strategies, compelling industry players to innovate across both product design and patient outreach.

Impact of 2025 U.S. Tariffs on Supply Chains and Cost Structures

With the introduction of tariff measures in the United States slated for 2025, supply chains and pricing models are facing renewed pressure. Import duties on specialized reagents, sequencing instruments, and laboratory consumables are elevating raw material costs, prompting manufacturers to evaluate alternative sourcing strategies. In response, some companies are forging partnerships with domestic suppliers or investing in in-house production capabilities to mitigate exposure. Meanwhile, distributors are adjusting their contractual terms to share cost fluctuations across the value chain, ensuring pricing remains competitive for end users. These tariff-induced adjustments extend to logistics and inventory management, as firms balance just-in-time delivery against the risks of stock shortages. Collectively, the cumulative effect of these duties underscores the importance of supply chain resilience and cost management in preserving margin integrity amid shifting trade policies.

Deep Dive into Key Segmentation Insights

Analysis of product type reveals distinct trajectories across carrier screening kits, general wellness kits, health risk assessment kits, heritage tests, and paternity tests. Carrier screening continues to gain traction among prospective parents seeking early insights, while general wellness offerings capitalize on consumer interest in proactive health. Health risk assessments integrate multifactorial data to inform lifestyle choices, and heritage tests attract individuals curious about genealogical origins. Paternity tests maintain steady demand from legal and personal inquiries alike. Application-based segmentation highlights the expanding role of ancestry and genealogy services, which dive into family tree analysis, genetic heritage, and heirloom connection to forge deeper personal narratives. Simultaneously, genetic disorder testing-spanning newborn screening, predictive testing, and prenatal screening-underpins clinical decision-making for at-risk populations. Health and wellness applications, including diet and nutrition, fitness planning, and stress management, leverage genomic insights to customize interventions; within diet and nutrition, focus on nutrient needs and personalized diet recommendations drives product refinement. Personalized medicine is also evolving through drug response assistance, emphasizing both adverse reaction identification and dosage optimization. Examining user types underscores the importance of forensic laboratories, which serve criminal cases and missing persons investigations, with paternity disputes representing a crucial sub-segment. Healthcare providers harness genetic data for patient care, while home users embrace at-home testing convenience. Research institutions continue to push scientific boundaries, fueling future innovations. Age group analysis shows engagement across life stages-from pediatric cohorts under 12 years to seniors over 60-each with unique testing motivations. Technology segmentation differentiates between array-based, mixed, and sequencing-based platforms; sequencing-based assays, whether next-generation or Sanger sequencing, drive high-resolution analysis. Finally, purchase channels vary across online retailers, pharmacies, and specialty stores, reflecting consumer preferences for accessibility, professional guidance, or targeted expertise.

Comparative Analysis of Global Regional Performance

Regional dynamics reveal distinct growth catalysts and operational considerations. In the Americas, robust direct-to-consumer adoption and widespread insurance reimbursements bolster demand for both clinical and wellness applications, while advanced infrastructure supports high-throughput sequencing operations. Europe, the Middle East, and Africa collectively exhibit a tapestry of regulatory environments, from stringent EU data protection frameworks to emerging markets where genetic literacy and laboratory capacity are expanding rapidly. In these territories, public-private collaborations and philanthropic initiatives are improving access to carrier screening and newborn testing. In the Asia-Pacific region, demographic diversity and rising healthcare expenditure are accelerating uptake, with key markets piloting large-scale population genomics projects. Localized manufacturing and strategic alliances with regional distributors are critical for navigating this heterogeneous landscape, ensuring regulatory compliance and cultural alignment.

Competitive Landscape and Leading Industry Participants

A competitive review underscores the diverse strategic approaches of leading players. 23andMe Inc. has advanced its pharmacogenomics offerings while maintaining strong consumer engagement through digital platforms. Ancestry.com LLC continues to refine its genealogical databases, integrating proprietary algorithms for deeper heritage insights. Color Genomics Inc. focuses on affordable hereditary cancer risk assessments, partnering with healthcare networks to expand clinical adoption. Dante Labs stands out with its comprehensive whole-genome sequencing packages, catering to research institutions and high-value consumers alike. DNAfit differentiates through bespoke fitness and nutrition programs grounded in genetic profiling, while EasyDNA leverages global laboratory networks to deliver rapid paternity and relationship testing. Embark Veterinary Inc. pioneers pet genetics, applying proprietary canine gene panels to improve animal health. FamilyTreeDNA and MyHeritage Ltd. both pursue enhanced ancestry analysis, with living DNA Ltd. emphasizing regional genetic diversity. Futura Genetics and Nebula Genomics champion open-access data models, whereas GenoPalate Inc. and Pathway Genomics Corporation refine diet and wellness offerings. Genos Inc. advances privacy-first data exchange frameworks; Helix OpCo LLC integrates cloud-based analysis tools; Mapmygenome India Ltd. tailors localized wellness solutions; Orig3n Inc. and Veritas Genetics Inc. drive clinical research collaborations; and Xcode Life Sciences delivers advanced pharmacogenomic decision support. Collectively, these companies demonstrate the strategic importance of technology differentiation, data stewardship, and partnership ecosystems.

Actionable Recommendations for Sustained Market Leadership

To thrive amid intensifying competition and evolving regulations, industry leaders should consider the following strategies:
  • Invest in modular platform architectures that support rapid assay development across emerging biomarkers.
  • Establish resilient supply chains through dual-sourcing agreements and strategic stock buffering to mitigate tariff and logistical disruptions.
  • Deepen integration with digital health ecosystems by offering API-driven data interoperability and telehealth partnerships for seamless test ordering and results delivery.
  • Prioritize data privacy and ethical governance frameworks, demonstrating compliance with global standards to build trust and facilitate market entry.
  • Expand direct-to-consumer channels with tiered service models, offering entry-level wellness tests alongside premium clinical panels to capture diverse user segments.
  • Foster collaborative research programs with academic and public health institutions to validate novel applications, support regulatory submissions, and enhance brand credibility.
  • Leverage artificial intelligence and machine learning to extract actionable insights from large genomic datasets, enabling predictive analytics and personalized recommendations.

Conclusion and Strategic Imperatives

The blood DNA kit market stands at a critical juncture, propelled by technological innovation, shifting regulatory landscapes, and an increasingly informed consumer base. As stakeholders navigate the complex interplay of supply chain challenges, tariff implications, and segmentation nuances, maintaining agility and customer-centric focus will be paramount. Those organizations that effectively harmonize robust product pipelines with data security, strategic partnerships, and adaptive marketing channels will capture enduring competitive advantage. Through a balanced emphasis on scientific rigor and operational excellence, industry participants can unlock new avenues for growth, expanding the reach and impact of genomic applications across clinical, wellness, and research domains.

Market Segmentation & Coverage

This research report categorizes the Blood DNA Kit Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Carrier Screening Kits
  • General Wellness Kits
  • Health Risk Assessment Kits
  • Heritage Tests
  • Paternity Tests
  • Ancestry and Genealogy
    • Family Tree Analysis
    • Genetic Heritage
    • Heirloom Connection
  • Genetic Disorders
    • Newborn Screening
    • Predictive Testing
    • Prenatal Screening
  • Health and Wellness
    • Diet and Nutrition
      • Nutrient Needs
      • Personalized Diet Recommendations
    • Fitness Planning
    • Stress Management
  • Personalized Medicine
    • Drug Response Assistance
      • Adverse Reactions
      • Dosage Optimization
  • Forensic Laboratories
    • Criminal Cases
      • Paternity Disputes
    • Missing Persons
  • Healthcare Providers
  • Home Users
  • Research Institutions
  • 0-12 Years
  • 13-18 Years
  • 19-35 Years
  • 36-60 Years
  • 60+ Years
  • Array-Based Technology
  • Mixed Technology
  • Sequencing-Based Technology
    • Next Generation Sequencing
    • Sanger Sequencing
  • Online Retailers
  • Pharmacies
  • Specialty Stores

This research report categorizes the Blood DNA Kit Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Blood DNA Kit Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 23andMe Inc.
  • Ancestry.com LLC
  • Color Genomics Inc.
  • Dante Labs
  • DNAfit
  • EasyDNA
  • Embark Veterinary Inc.
  • FamilyTreeDNA
  • Futura Genetics
  • GenoPalate Inc.
  • Genos Inc.
  • Helix OpCo LLC
  • Living DNA Ltd.
  • Mapmygenome India Ltd.
  • MyHeritage Ltd.
  • Nebula Genomics
  • Orig3n Inc.
  • Pathway Genomics Corporation
  • Veritas Genetics Inc.
  • Xcode Life Sciences

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood DNA Kit Market, by Product Type
8.1. Introduction
8.2. Carrier Screening Kits
8.3. General Wellness Kits
8.4. Health Risk Assessment Kits
8.5. Heritage Tests
8.6. Paternity Tests
9. Blood DNA Kit Market, by Application
9.1. Introduction
9.2. Ancestry and Genealogy
9.2.1. Family Tree Analysis
9.2.2. Genetic Heritage
9.2.3. Heirloom Connection
9.3. Genetic Disorders
9.3.1. Newborn Screening
9.3.2. Predictive Testing
9.3.3. Prenatal Screening
9.4. Health and Wellness
9.4.1. Diet and Nutrition
9.4.1.1. Nutrient Needs
9.4.1.2. Personalized Diet Recommendations
9.4.2. Fitness Planning
9.4.3. Stress Management
9.5. Personalized Medicine
9.5.1. Drug Response Assistance
9.5.1.1. Adverse Reactions
9.5.1.2. Dosage Optimization
10. Blood DNA Kit Market, by User Type
10.1. Introduction
10.2. Forensic Laboratories
10.2.1. Criminal Cases
10.2.1.1. Paternity Disputes
10.2.2. Missing Persons
10.3. Healthcare Providers
10.4. Home Users
10.5. Research Institutions
11. Blood DNA Kit Market, by Age Group
11.1. Introduction
11.2. 0-12 Years
11.3. 13-18 Years
11.4. 19-35 Years
11.5. 36-60 Years
11.6. 60+ Years
12. Blood DNA Kit Market, by Technology
12.1. Introduction
12.2. Array-Based Technology
12.3. Mixed Technology
12.4. Sequencing-Based Technology
12.4.1. Next Generation Sequencing
12.4.2. Sanger Sequencing
13. Blood DNA Kit Market, by Purchase Channel
13.1. Introduction
13.2. Online Retailers
13.3. Pharmacies
13.4. Specialty Stores
14. Americas Blood DNA Kit Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Blood DNA Kit Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Blood DNA Kit Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. 23andMe Inc.
17.3.2. Ancestry.com LLC
17.3.3. Color Genomics Inc.
17.3.4. Dante Labs
17.3.5. DNAfit
17.3.6. EasyDNA
17.3.7. Embark Veterinary Inc.
17.3.8. FamilyTreeDNA
17.3.9. Futura Genetics
17.3.10. GenoPalate Inc.
17.3.11. Genos Inc.
17.3.12. Helix OpCo LLC
17.3.13. Living DNA Ltd.
17.3.14. Mapmygenome India Ltd.
17.3.15. MyHeritage Ltd.
17.3.16. Nebula Genomics
17.3.17. Orig3n Inc.
17.3.18. Pathway Genomics Corporation
17.3.19. Veritas Genetics Inc.
17.3.20. Xcode Life Sciences
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BLOOD DNA KIT MARKET MULTI-CURRENCY
FIGURE 2. BLOOD DNA KIT MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD DNA KIT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BLOOD DNA KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BLOOD DNA KIT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD DNA KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD DNA KIT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD DNA KIT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CARRIER SCREENING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENERAL WELLNESS KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH RISK ASSESSMENT KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HERITAGE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FAMILY TREE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC HERITAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEIRLOOM CONNECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PREDICTIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NUTRIENT NEEDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED DIET RECOMMENDATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FITNESS PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD DNA KIT MARKET SIZE, BY STRESS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ADVERSE REACTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DOSAGE OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PATERNITY DISPUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MISSING PERSONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD DNA KIT MARKET SIZE, BY HOME USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BLOOD DNA KIT MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BLOOD DNA KIT MARKET SIZE, BY 0-12 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD DNA KIT MARKET SIZE, BY 13-18 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BLOOD DNA KIT MARKET SIZE, BY 19-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD DNA KIT MARKET SIZE, BY 36-60 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BLOOD DNA KIT MARKET SIZE, BY 60+ YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ARRAY-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD DNA KIT MARKET SIZE, BY MIXED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD DNA KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD DNA KIT MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BLOOD DNA KIT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD DNA KIT MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. CANADA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. CANADA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. CANADA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 113. CANADA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 114. CANADA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 115. CANADA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 116. CANADA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 117. CANADA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 118. CANADA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 120. CANADA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 121. CANADA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. CANADA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. CANADA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. CANADA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. MEXICO BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. MEXICO BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 128. MEXICO BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 131. MEXICO BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BLOOD DNA KIT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BLOOD DNA KIT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. CHINA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. CHINA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. CHINA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 190. CHINA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 191. CHINA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 192. CHINA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 193. CHINA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 194. CHINA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 195. CHINA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 196. CHINA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 197. CHINA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 198. CHINA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 199. CHINA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. CHINA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. CHINA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. INDIA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDIA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. INDIA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 205. INDIA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 206. INDIA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 207. INDIA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 208. INDIA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 209. INDIA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 210. INDIA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 211. INDIA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 212. INDIA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 213. INDIA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. INDIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. INDIA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. INDIA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. JAPAN BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. JAPAN BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. JAPAN BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 235. JAPAN BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 236. JAPAN BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 237. JAPAN BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 238. JAPAN BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 239. JAPAN BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 240. JAPAN BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 241. JAPAN BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 242. JAPAN BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 243. JAPAN BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. JAPAN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. JAPAN BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. JAPAN BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 310. TAIWAN BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 311. TAIWAN BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 312. TAIWAN BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 313. TAIWAN BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 314. TAIWAN BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. THAILAND BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. THAILAND BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. THAILAND BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 325. THAILAND BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 326. THAILAND BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 327. THAILAND BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 328. THAILAND BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 329. THAILAND BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 330. THAILAND BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 331. THAILAND BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 332. THAILAND BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 333. THAILAND BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 334. THAILAND BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 335. THAILAND BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 336. THAILAND BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 337. VIETNAM BLOOD DNA KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. VIETNAM BLOOD DNA KIT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 339. VIETNAM BLOOD DNA KIT MARKET SIZE, BY ANCESTRY AND GENEALOGY, 2018-2030 (USD MILLION)
TABLE 340. VIETNAM BLOOD DNA KIT MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 341. VIETNAM BLOOD DNA KIT MARKET SIZE, BY HEALTH AND WELLNESS, 2018-2030 (USD MILLION)
TABLE 342. VIETNAM BLOOD DNA KIT MARKET SIZE, BY DIET AND NUTRITION, 2018-2030 (USD MILLION)
TABLE 343. VIETNAM BLOOD DNA KIT MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 344. VIETNAM BLOOD DNA KIT MARKET SIZE, BY DRUG RESPONSE ASSISTANCE, 2018-2030 (USD MILLION)
TABLE 345. VIETNAM BLOOD DNA KIT MARKET SIZE, BY USER TYPE, 2018-2030 (USD MILLION)
TABLE 346. VIETNAM BLOOD DNA KIT MARKET SIZE, BY FORENSIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 347. VIETNAM BLOOD DNA KIT MARKET SIZE, BY CRIMINAL CASES, 2018-2030 (USD MILLION)
TABLE 348. VIETNAM BLOOD DNA KIT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 349. VIETNAM BLOOD DNA KIT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM BLOOD DNA KIT MARKET SIZE, BY SEQUENCING-BASED TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM BLOOD DNA KIT MARKET SIZE, BY PURCHASE CHANNEL, 2018-2030 (USD MILLION)
TABLE 352. EUROPE, MIDDLE EAST & AFRICA BLOOD DNA KIT MARKET SIZE, BY

Companies Mentioned

  • 23andMe Inc.
  • Ancestry.com LLC
  • Color Genomics Inc.
  • Dante Labs
  • DNAfit
  • EasyDNA
  • Embark Veterinary Inc.
  • FamilyTreeDNA
  • Futura Genetics
  • GenoPalate Inc.
  • Genos Inc.
  • Helix OpCo LLC
  • Living DNA Ltd.
  • Mapmygenome India Ltd.
  • MyHeritage Ltd.
  • Nebula Genomics
  • Orig3n Inc.
  • Pathway Genomics Corporation
  • Veritas Genetics Inc.
  • Xcode Life Sciences

Methodology

Loading
LOADING...

Related Topics

Related Reports

Blood Relationship Testing Service Market - Global Forecast to 2030 - Product Image

Blood Relationship Testing Service Market - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
DNA Test Kits Market Report 2025 - Product Image

DNA Test Kits Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Nucleic Acid Isolation And Purification - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Nucleic Acid Isolation And Purification - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 112 Pages
  • Global
From
DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Forecast to 2029 - Product Image

DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Forecast to 2029

  • Report
  • 334 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.